Locally Delivered Umbilical Cord Mesenchymal Stromal Cells Reduce Chronic Inflammation in Long-Term Nonhealing Wounds: A Randomized Study

Stem Cells International
Yulia SuzdaltsevaVictor Stupin

Abstract

Inflammation is part of a complex biological response to injury that mediates a rapid mobilization of cells and triggers the restoration of tissue homeostasis. The systemic diseases of the connective tissues, repetitive strain injuries, neuropathy, and vascular impairment lead to the development of a chronic inflammatory state. In such cases, a forced intervention is required to trigger tissue regeneration. Mesenchymal stromal cells (MSCs) have been considered a perspective tool for regenerative medicine because of their ability to change the expression and secretory profile under the influence of signals from the microenvironment to perform a regulatory function at the site of tissue damage. In this study, MSCs were isolated from the human umbilical cord (UCMSCs). The ability of UCMSCs to regulate chronic inflammation was investigated in a randomized placebo-controlled pilot study to assess the efficacy and safety of UCMSC therapy in patients with nonhealing wounds. A total of 108 patients with chronic wounds of different etiologies were randomly divided into two groups according to the criteria of inclusion and exclusion. The group (n = 59) that was treated with a single local subcutaneous infusion of UCMSCs around the wound ...Continue Reading

References

Sep 2, 1999·The New England Journal of Medicine·A J Singer, R A Clark
Apr 25, 2006·Experimental Cell Research·Ida Rasmusson
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alma J NautaWillem E Fibbe
Aug 26, 2006·Bulletin of Experimental Biology and Medicine·K N YaryginV N Yarygin
Apr 7, 2007·Bulletin of Experimental Biology and Medicine·A Yu LupatovK N Yarygin
Nov 21, 2007·Bulletin of Experimental Biology and Medicine·Yu G Suzdal'tsevaK N Yarygin
Nov 26, 2008·Bulletin of Experimental Biology and Medicine·Yu G SuzdaltsevaK N Yarygin
Sep 4, 2009·Journal of Cell Science·Tanya J Shaw, Paul Martin
Mar 13, 2010·Fibrogenesis & Tissue Repair·Beate EckesThomas Krieg
May 28, 2010·Stem Cell Research & Therapy·Soufiane GhannamDanièle Noël
Nov 16, 2010·Annual Review of Pathology·Nora G Singer, Arnold I Caplan
Jul 13, 2011·Annals of Dermatology·Seung Ho LeeKwang Hyun Cho
Sep 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Moïra FrançoisJacques Galipeau
Jun 27, 2012·Clinics in Plastic Surgery·Sadanori AkitaShunichi Yamashita
Oct 26, 2012·The Journal of Pathology·Alberto MantovaniMassimo Locati
Jun 13, 2013·Journal of Tissue Viability·Ganary Dabiri, Vincent Falanga
Apr 17, 2015·Stem Cell Research & Therapy·Luis Rodriguez-MenocalEvangelos Van Badiavas
Aug 1, 2015·International Journal of Hematology·Haiping HeArinobu Tojo
Oct 30, 2015·International Journal of Molecular Sciences·Maximina H Yun
Sep 11, 2016·Stem Cell Research & Therapy·Sami G Almalki, Devendra K Agrawal
Dec 16, 2016·International Journal of Molecular Sciences·Ruilong ZhaoMeilang Xue
Dec 16, 2016·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·Heiko SorgUrsula Mirastschijski
Jan 22, 2017·Advances in Therapy·George Han, Roger Ceilley
Jul 18, 2017·International Journal of Molecular Sciences·Mark HeskethRachael Z Murray

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.